2/26/2021NMPA Announces Package Insert Revision of Misoprostol Tablets

2/9/2021NMPA Revises Packages Inserts of Thiamazole Formulations

1/14/2021China Officially Bans Phenolphthalein Tablets and Lozenges Due to Seri...

12/10/2020NMPA Solicits Comments on the Draft Measures for Drug Annual Reports

8/3/2020NMPA Solicits Comments on the Measures of Post Marketing Changes of Dr...

7/30/2020NMPA Issues Policy for Further Strengthening the ADR Monitoring and Ap...

4/14/2020NMPA Publishes 2019 Annual Report for Adverse Drug Reaction Monitoring

10/17/2019NMPA Publishes 2018 Annual Report for Adverse Drug Reaction Monitoring

3/27/2019NMPA's CDR Solicits Comments on ADR Annual Report Drafting Guidelines ...

3/7/2019NMPA Announces Package Insert Revision of Cefoperazone Sodium and Amox...

2/25/2019NMPA Holds National Drug ADR Conference, Outlining Major Tasks in 2019

2/15/2019NMPA Bans Compound Formulations Containing Furazolidone

1/21/2019Huahai Pharma Involved In Another Blood Pressure Drug Recall

12/21/2018NMPA Issues the Guidelines for Individual ADR Case Collection and Repo...

9/30/2018NMPA Issues Announcement Regarding Direct ADR Reporting by MAHs

9/7/2018NMPA Solicits Comments on Draft Guidelines on Collection and Reporting...

4/13/2018CNDA Publishes 2017 Annual Report for Adverse Drug Reaction Monitoring

12/28/2017CFDA Solicits Comments on Draft Announcement for ADR Direct Reporting ...

7/5/2017CFDA Issues Announcement for Package Insert Revision of Systemic Quino...

4/28/2017CFDA Publishes 2016 Annual Report for Adverse Drug Reaction Monitoring

7/13/2016CFDA Publishes 2015 Annual Report for Adverse Drug Reaction Monitoring

1/18/2016CFDA Suspends Production and Sales of Calf Serum Products behind the S...

7/21/2015CFDA Publishes 2014 Annual Report for Adverse Drug Reaction Monitoring

6/30/2015CFDA Terminates Production and Sales of Ketoconazole Oral Formulations

5/14/2014CFDA Publishes 2013 Annual Adverse Drug Reaction Report

12/21/2013CFDA and NHFPC Suspends Problem HepB Vaccine of BioKangtai

11/21/2013CFDA Issues Warning on ADRs of Fluoroquinolones

6/14/2013CFDA Talks to J&J over Drug Quality and Product Recall

6/3/2013CFDA Issues Warning over Risks and Interactions of PPIs and Clopidogre...

3/26/2013CFDA Seeks Comments on New Document for Priority Surveillance of Drugs

Page:2/5 Total number of articles:122: [First][<<] [1] [2] [3] [4] [5] [>>] [End]